|
TTC35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.602000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.619800E-02 |
| Normal-vs-Stage2 |
5.312100E-02 |
| Normal-vs-Stage3 |
1.710970E-01 |
| Normal-vs-Stage4 |
5.070200E-02 |
| Stage1-vs-Stage2 |
2.638400E-01 |
| Stage1-vs-Stage3 |
6.561700E-03 |
| Stage1-vs-Stage4 |
2.440600E-03 |
| Stage2-vs-Stage3 |
1.086060E-02 |
| Stage2-vs-Stage4 |
4.137100E-03 |
| Stage3-vs-Stage4 |
5.796200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.134600E-01 |
| Normal-vs-AfricanAmerican |
7.291800E-01 |
| Normal-vs-Asian |
9.908400E-01 |
| Caucasian-vs-AfricanAmerican |
5.632000E-01 |
| Caucasian-vs-Asian |
9.104600E-01 |
| AfricanAmerican-vs-Asian |
8.985000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.242200E-01 |
| Normal-vs-Female |
1.150060E-02 |
| Male-vs-Female |
6.770500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.821980E-01 |
| Normal-vs-Age(41-60Yrs) |
4.103600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.919800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.533200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.449800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.842770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.695180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.493600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.075600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.008400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.895400E-03 |
| Normal-vs-Grade 2 |
2.840200E-03 |
| Normal-vs-Grade 3 |
1.615590E-01 |
| Normal-vs-Grade 4 |
5.429900E-04 |
| Grade 1-vs-Grade 2 |
2.133600E-01 |
| Grade 1-vs-Grade 3 |
8.774300E-04 |
| Grade 1-vs-Grade 4 |
3.93979999999683E-05 |
| Grade 2-vs-Grade 3 |
3.53379999999959E-05 |
| Grade 2-vs-Grade 4 |
4.7697000016278E-08 |
| Grade 3-vs-Grade 4 |
1.104110E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.80950000000002E-05 |
| Normal-vs-ccB subtype |
6.589900E-02 |
| ccA subtype-vs-ccB subtype |
1.24259999956244E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.748000E-01 |
| Normal-vs-N1 |
1.306270E-02 |
| N0-vs-N1 |
1.856260E-02 |
|
|
